China Prosperity Announces Successful Start-Up of PTA Plant

China Prosperity (Jiangyin) Petrochemical and INVISTA Performance Technologies (IPT), an integrated manufacturer of fibers and polymers, have proclaimed that China Prosperity’s PTA facility, which has an annual production capacity of 600,000 tons, has successfully initiated its operation.

China Prosperity uses INVISTA’s PTA process technology at the PTA facility located in Shizhuang chemical concentration area Jiangyin economic and technical development zone. IPT offers the PTA technology as a license package.

The General Manager of IPT, Mike Pickens, commented that the PTA facility has already surpassed its design flowsheet rate within a few days following its initiation. It has set a new benchmark in the company’s relationship with Jiangyin Chengxing Industrial Group, Pickens said.

The Chairman and President of Jiangyin Chengxing Industrial Group and the Chairman of China Prosperity, Li Xing, stated that the company is happy about INVISTA’s support in the development of the PTA project.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). China Prosperity Announces Successful Start-Up of PTA Plant. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=28366.

  • MLA

    Chai, Cameron. "China Prosperity Announces Successful Start-Up of PTA Plant". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=28366>.

  • Chicago

    Chai, Cameron. "China Prosperity Announces Successful Start-Up of PTA Plant". AZoM. https://www.azom.com/news.aspx?newsID=28366. (accessed November 22, 2024).

  • Harvard

    Chai, Cameron. 2019. China Prosperity Announces Successful Start-Up of PTA Plant. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=28366.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.